Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Stepwise Expression of CDKN2A and RB1 Proteins in Esophageal Mucosa From Patients at High Risk for Squamous Cell Carcinoma

Stepwise Expression of CDKN2A and RB1 Proteins in Esophageal Mucosa From Patients at High Risk... RESEARCH ARTICLE Stepwise Expression of CDKN2A and RB1 Proteins in Esophageal Mucosa From Patients at High Risk for Squamous Cell Carcinoma Leandro B. Muller, MD,*w Luise Meurer, MD, PhD,*z Antoˆnio Barros Lopes, MD,* Luis C.M. Antunes, MD,* Sara Vanazzi, MD,*y and Renato B. Fagundes, MD, PhD*8 sophageal cancer is the sixth leading cause of cancer Abstract: Squamous cell carcinoma of the esophagus is a lethal Edeath worldwide. Its high mortality is associated with cancer and carries a poor prognosis because of late diagnosis. late diagnosis, which reduces the chances of curative 2,3 Identification of molecular markers may aid early diagnosis. We therapy. In southern Brazil, squamous cell carcinoma assessed the expression of CDKN2A/RB1 in the esophageal of the esophagus (SCCE) accounts for almost 90% of mucosa and its association with the histology. Esophageal bi- malignancies in this organ. The main risk factors opsies were collected from 38 patients with no esophageal lesion worldwide for this cancer are tobacco and alcohol con- 5–11 (group 1), from iodine-negative areas of 108 alcoholics/smokers sumption. (group 2), and from tumor and nontumor areas in 41 patients The identification of precursor lesions found in the with squamous cell carcinoma (group 3). The histologic diag- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Stepwise Expression of CDKN2A and RB1 Proteins in Esophageal Mucosa From Patients at High Risk for Squamous Cell Carcinoma

Loading next page...
 
/lp/wolters-kluwer-health/stepwise-expression-of-cdkn2a-and-rb1-proteins-in-esophageal-mucosa-usE1mW2wlk

References (45)

Copyright
Copyright © 2014 by Lippincott Williams & Wilkins
ISSN
1541-2016
DOI
10.1097/PAI.0000000000000011
pmid
25046224
Publisher site
See Article on Publisher Site

Abstract

RESEARCH ARTICLE Stepwise Expression of CDKN2A and RB1 Proteins in Esophageal Mucosa From Patients at High Risk for Squamous Cell Carcinoma Leandro B. Muller, MD,*w Luise Meurer, MD, PhD,*z Antoˆnio Barros Lopes, MD,* Luis C.M. Antunes, MD,* Sara Vanazzi, MD,*y and Renato B. Fagundes, MD, PhD*8 sophageal cancer is the sixth leading cause of cancer Abstract: Squamous cell carcinoma of the esophagus is a lethal Edeath worldwide. Its high mortality is associated with cancer and carries a poor prognosis because of late diagnosis. late diagnosis, which reduces the chances of curative 2,3 Identification of molecular markers may aid early diagnosis. We therapy. In southern Brazil, squamous cell carcinoma assessed the expression of CDKN2A/RB1 in the esophageal of the esophagus (SCCE) accounts for almost 90% of mucosa and its association with the histology. Esophageal bi- malignancies in this organ. The main risk factors opsies were collected from 38 patients with no esophageal lesion worldwide for this cancer are tobacco and alcohol con- 5–11 (group 1), from iodine-negative areas of 108 alcoholics/smokers sumption. (group 2), and from tumor and nontumor areas in 41 patients The identification of precursor lesions found in the with squamous cell carcinoma (group 3). The histologic diag-

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Oct 1, 2014

There are no references for this article.